471 related articles for article (PubMed ID: 28400445)
1. MicroRNA-23a and MicroRNA-27a Mimic Exercise by Ameliorating CKD-Induced Muscle Atrophy.
Wang B; Zhang C; Zhang A; Cai H; Price SR; Wang XH
J Am Soc Nephrol; 2017 Sep; 28(9):2631-2640. PubMed ID: 28400445
[TBL] [Abstract][Full Text] [Related]
2. miRNA-23a/27a attenuates muscle atrophy and renal fibrosis through muscle-kidney crosstalk.
Zhang A; Li M; Wang B; Klein JD; Price SR; Wang XH
J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):755-770. PubMed ID: 29582582
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486.
Xu J; Li R; Workeneh B; Dong Y; Wang X; Hu Z
Kidney Int; 2012 Aug; 82(4):401-11. PubMed ID: 22475820
[TBL] [Abstract][Full Text] [Related]
4. Smad3 induces atrogin-1, inhibits mTOR and protein synthesis, and promotes muscle atrophy in vivo.
Goodman CA; McNally RM; Hoffmann FM; Hornberger TA
Mol Endocrinol; 2013 Nov; 27(11):1946-57. PubMed ID: 24002653
[TBL] [Abstract][Full Text] [Related]
5. Excessive glucocorticoid-induced muscle MuRF1 overexpression is independent of Akt/FoXO1 pathway.
Wang XJ; Xiao JJ; Liu L; Jiao HC; Lin H
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29046370
[TBL] [Abstract][Full Text] [Related]
6. Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy.
Léger B; Cartoni R; Praz M; Lamon S; Dériaz O; Crettenand A; Gobelet C; Rohmer P; Konzelmann M; Luthi F; Russell AP
J Physiol; 2006 Nov; 576(Pt 3):923-33. PubMed ID: 16916907
[TBL] [Abstract][Full Text] [Related]
7. PI3K-AKT-FOXO1 pathway targeted by skeletal muscle microRNA to suppress proteolytic gene expression in response to carbohydrate intake during aerobic exercise.
Margolis LM; Berryman CE; Murphy NE; Carrigan CT; Young AJ; Carbone JW; Pasiakos SM
Physiol Rep; 2018 Dec; 6(23):e13931. PubMed ID: 30548426
[TBL] [Abstract][Full Text] [Related]
8. Iron-induced skeletal muscle atrophy involves an Akt-forkhead box O3-E3 ubiquitin ligase-dependent pathway.
Ikeda Y; Imao M; Satoh A; Watanabe H; Hamano H; Horinouchi Y; Izawa-Ishizawa Y; Kihira Y; Miyamoto L; Ishizawa K; Tsuchiya K; Tamaki T
J Trace Elem Med Biol; 2016 May; 35():66-76. PubMed ID: 27049128
[TBL] [Abstract][Full Text] [Related]
9.
Wang B; Zhang A; Wang H; Klein JD; Tan L; Wang ZM; Du J; Naqvi N; Liu BC; Wang XH
Theranostics; 2019; 9(7):1864-1877. PubMed ID: 31037144
[TBL] [Abstract][Full Text] [Related]
10. Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size.
Trendelenburg AU; Meyer A; Rohner D; Boyle J; Hatakeyama S; Glass DJ
Am J Physiol Cell Physiol; 2009 Jun; 296(6):C1258-70. PubMed ID: 19357233
[TBL] [Abstract][Full Text] [Related]
11. Smad2/3 Proteins Are Required for Immobilization-induced Skeletal Muscle Atrophy.
Tando T; Hirayama A; Furukawa M; Sato Y; Kobayashi T; Funayama A; Kanaji A; Hao W; Watanabe R; Morita M; Oike T; Miyamoto K; Soga T; Nomura M; Yoshimura A; Tomita M; Matsumoto M; Nakamura M; Toyama Y; Miyamoto T
J Biol Chem; 2016 Jun; 291(23):12184-94. PubMed ID: 27129272
[TBL] [Abstract][Full Text] [Related]
12. Atrogin-1, MuRF1, and FoXO, as well as phosphorylated GSK-3beta and 4E-BP1 are reduced in skeletal muscle of chronic spinal cord-injured patients.
Léger B; Senese R; Al-Khodairy AW; Dériaz O; Gobelet C; Giacobino JP; Russell AP
Muscle Nerve; 2009 Jul; 40(1):69-78. PubMed ID: 19533653
[TBL] [Abstract][Full Text] [Related]
13. Leucine promotes porcine myofibre type transformation from fast-twitch to slow-twitch through the protein kinase B (Akt)/forkhead box 1 signalling pathway and microRNA-27a.
Zhang S; Chen X; Huang Z; Chen D; Yu B; Chen H; He J; Luo J; Zheng P; Yu J; Luo Y
Br J Nutr; 2019 Jan; 121(1):1-8. PubMed ID: 30449288
[TBL] [Abstract][Full Text] [Related]
14. Myostatin induces degradation of sarcomeric proteins through a Smad3 signaling mechanism during skeletal muscle wasting.
Lokireddy S; McFarlane C; Ge X; Zhang H; Sze SK; Sharma M; Kambadur R
Mol Endocrinol; 2011 Nov; 25(11):1936-49. PubMed ID: 21964591
[TBL] [Abstract][Full Text] [Related]
15. Influence of divergent exercise contraction mode and whey protein supplementation on atrogin-1, MuRF1, and FOXO1/3A in human skeletal muscle.
Stefanetti RJ; Lamon S; Rahbek SK; Farup J; Zacharewicz E; Wallace MA; Vendelbo MH; Russell AP; Vissing K
J Appl Physiol (1985); 2014 Jun; 116(11):1491-502. PubMed ID: 24458747
[TBL] [Abstract][Full Text] [Related]
16. Mice overexpressing growth hormone exhibit increased skeletal muscle myostatin and MuRF1 with attenuation of muscle mass.
Consitt LA; Saneda A; Saxena G; List EO; Kopchick JJ
Skelet Muscle; 2017 Sep; 7(1):17. PubMed ID: 28870245
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic effect of massage on denervated skeletal muscle atrophy in rats and its mechanism].
Wan XF; Tang CL; Zhao DD; An HY; Ma X; Qiao TX
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2019 May; 35(3):223-227. PubMed ID: 31257803
[TBL] [Abstract][Full Text] [Related]
18. Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease.
Doucet M; Russell AP; Léger B; Debigaré R; Joanisse DR; Caron MA; LeBlanc P; Maltais F
Am J Respir Crit Care Med; 2007 Aug; 176(3):261-9. PubMed ID: 17478621
[TBL] [Abstract][Full Text] [Related]
19. miR-23a is decreased during muscle atrophy by a mechanism that includes calcineurin signaling and exosome-mediated export.
Hudson MB; Woodworth-Hobbs ME; Zheng B; Rahnert JA; Blount MA; Gooch JL; Searles CD; Price SR
Am J Physiol Cell Physiol; 2014 Mar; 306(6):C551-8. PubMed ID: 24336651
[TBL] [Abstract][Full Text] [Related]
20. Isometric resistance exercise fails to counteract skeletal muscle atrophy processes during the initial stages of unloading.
Haddad F; Adams GR; Bodell PW; Baldwin KM
J Appl Physiol (1985); 2006 Feb; 100(2):433-41. PubMed ID: 16239603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
